Delivery Order SPE2DB22D1202-SPE2DB24FUNX0
Award Date 1/29/24
Potential Completion Date 1/30/24
Potential Value $8K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $12,893.60 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TOPAMAX 50 MG TABLET 60S, a pharmaceutical product. This delivery order contract has an ultimate completion date of March 18, 2024 and was awarded on March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation, to supply TOPAMAX 50 MG TABLET 60S medication. The $10,915.77 award has an ultimate completion date of April 11, 2024 and is not associated with any set-aside designations. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide TOPAMAX 50 MG TABLET 60S, a pharmaceutical product. The contract has a potential value of $10,765.92 and a completion date of February 20, 2024. This order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which serves as the primary vehicle for the company to deliver...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide TOPAMAX 200 MG TABLET 60S, a pharmaceutical product. The $4,075.26 contract has a completion date of February 12, 2024 and does not utilize any set-aside designations. This delivery order is issued under Amerisourcebergen Drug Corp's indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December 31,...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a Firm Fixed Price Delivery Order contract by the Defense Logistics Agency (DLA) to provide TOPAMAX 50 MG TABLET 60S. The total potential value of the contract is $8,629.35 with a completion date of February 22, 2024. This contract is not associated with any set-aside designation. Amerisourcebergen Drug Corp serves as the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA, with a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the supply of TOPAMAX 50 MG TABLET 60S, a pharmaceutical product, with a potential value of $10,654.07 and a completion date of February 28, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation...
- This federal contract award, valued at $4,240.57, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of TOPAMAX 50 MG TABLET 60S, a pharmaceutical product, and is a firm fixed price delivery order with an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,564,110,277 units of the pharmaceutical product TOPAMAX 25 MG SPRINKLE CAP 60S. The contract has an ultimate completion date of March 29, 2024 and a ceiling value of $1,559.40. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA, valued up to $999,999,999.00, which serves as the...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is to provide TOPAMAX 200 MG TABLET 60S, a pharmaceutical product, with a potential value of $6,962.51 and a completion date of January 2, 2024. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is a prime contractor that has received multiple federal...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $24,597.74 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of Topamax 50 mg tablets. This contract is a task order issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen to supply...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUNX0Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TOPAMAX 200 MG TABLET 60S. The $8,026.69 award has a completion date of January 30, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and is also the prime on an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Generated 4/29/24, 10:05 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 1/29/24 |